Írland - enska - HPRA (Health Products Regulatory Authority)

teva b.v. - melphalan - pdr+solv for soln for inf/inj - 50 milligram - melphalan

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - melphalan, quantity: 50 mg - injection, powder for - excipient ingredients: povidone; hydrochloric acid - for the treatment of patients with multiple myeloma for whom oral therapy is not appropriate

Bandaríkin - enska - NLM (National Library of Medicine)

apopharma usa, inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - alkeran for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg

Bandaríkin - enska - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

Bandaríkin - enska - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

Ísrael - enska - Ministry of Health

raz pharmaceutics ltd, israel - melphalan as hydrochloride - powder and solvent for solution for injection/infusion - melphalan as hydrochloride 50 mg - melphalan - for the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial cancer of the ovary.